Investor mix
15 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 47% |
| Private equity | 2 | 13% |
| Accelerator & incubator | 1 | 7% |
| Bank & private debt | 2 | 13% |
| Other / undisclosed | 3 | 20% |
Small molecule therapeutics that selectively inhibit NOX enzymes
15 investors on record.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 7 | 47% |
| Private equity | 2 | 13% |
| Accelerator & incubator | 1 | 7% |
| Bank & private debt | 2 | 13% |
| Other / undisclosed | 3 | 20% |